TO THE EDITOR
The Philadelphia chromosome (Ph) is the result of the chromosomal translocation t(9;22)(q34;q11), leading to the BCR-ABL1 fusion gene. The Ph chromosome is the hallmark of chronic myeloid leukemia (CML), but is also detected in acute lymphoblastic leukemia (ALL), particularly in adults. The majority of Ph-positive ALL cases belong to the category of Bcell precursor ALL, whereas Ph-positive T-ALL cases are rather rare. We recently identified a novel NUP214-ABL1 fusion gene in approximately 5% of T-ALL cases and in three independent T-ALL cell lines, indicating that oncogenic ABL1 fusions are recurrent in T-ALL. 1 Here, we report on a T-ALL cell line expressing the e6-a2 BCR-ABL1 fusion transcript described so far only in five cases of CML. [2] [3] [4] [5] [6] The MHH-TALL1 cell line was established from the peripheral blood of an 11-year old boy with T-ALL in 1993. 7 Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of primary tumor cells at the time of the initial diagnosis failed to reveal the existence of a BCR-ABL1 fusion. Interestingly, however, conventional cytogenetics and fluorescence in situ hybridization performed on the cell line showed a three-way t(1;9;22)(q32;q34;q11) rearrangement effecting Ph formation ( Figure 1) . As with the patient, RT-PCR of the various conventional BCR-ABL1 fusion transcripts was negative in the cell line. However, we found a PCR product that was about 600 bp larger than the e1-a2 BCR-ABL1 transcript caused by a break in the BCR minor breakpoint cluster region Figure 1 MHH-TALL1 carries t(1;9;22)(q32;q34;q11). The FISH images in (a) and (b) respectively depict representative metaphases prepared from MHH-TALL1 and hybridized with 'break-apart' probes for BCR at 22q11 (Dako, Glostrup, Denmark) and ABL1 on 9q34 (BAC clones, RP11-57c19/83j21, Childreń s Hospital, Oakland, CA, USA). Preparations were counterstained with DAPI. (a) (Nonreciprocal) Three-way t(1;9;22)(q32;q34;q11) forming der(22)/Ph (red signal) and der(1) (green signal) are shown. In (b), note translocation breakpoint lies within RP11-83j21 (red signal) that covers 3 0 ABL1 (exons 1a-11), and pericentric inversion of nonparticipant chromosome 9 homologue. Pseudocolor images were visualized using an Axioscop 2 microscope (Zeiss, Gö ttingen, Germany) and analyzed using Smart Capture 2 software (Applied Imaging, Newcastle, UK). (m-bcr) (Figure 2a) . Sequencing of the RT-PCR product showed that MHH-TALL1 expresses the e6-a2 BCR-ABL1 fusion transcript. Western blot analyses confirmed the expression of the fusion gene (Figure 2b ). The size of the constitutively phosphorylated chimeric protein was about 200 kDa, clearly distinguishable from the 190 and 210 kDa BCR-ABL1 variants resulting from breaks in the BCR m-bcr or major-bcr (M-bcr) (Figure 2b ). In summary, we describe an e6-a2 BCR-ABL1 fusion in a T-ALL cell line. This variant has been reported so far in rare cases of CML, but not in ALL. RT-PCR conditions had to be optimized to detect this BCR-ABL1 variant clearly. Therefore, our data raise the intriguing possibility that an unknown percentage of allegedly BCR-ABL1 negative cases of both CML and ALL may express the e6-a2 transcript. This finding carries obvious implications for the diagnosis of ALL/CML and for their treatment with ABL kinase inhibitors. 1 At a critical telomere length, cells enter senescence or apoptosis. Cells can get immortal by stabilizing the length of their telomeres by activation of the multisubunit enzyme telomerase. In about 85% of all human tumours telomerase activity (TA) has been detected, whereas TA is absent in most normal cells. 2 The presence of TA is limited by the expression of the catalytic subunit of telomerase hTERT (human telomerase reverse transcriptase). 1 It has been shown that TA is a prognostic marker in some solid tumours as well as in haematologic neoplasias. 2 In contrast to solid tumours, few studies exist in haematologic neoplasias regarding TA and telomere length.
Acute lymphoblastic leukaemia (ALL) is the most frequently diagnosed malignancy in childhood and is responsible for more than 80% of childhood leukaemias, whereas the T-cell phenotype accounts for about 10% of diagnosed children with ALL. So far a few reports have been published in terms of telomere length and/or TA in paediatric leukaemic malignancies; [3] [4] [5] [6] [7] [8] [9] however, systematic analyses about TA and telomere length in paediatric patients with T-ALL are still missing.
Although prognosis of T-ALL in childhood has improved with modern chemotherapy, T-ALL patients with failure of inducing a remission or after first relapse still have a very poor prognosis. 10 It is anticipated that new biochemical information might contribute to better therapeutic strategies. In order to investigate the prognostic significance of telomere length, TA and expression of hTERT in paediatric patients with T-ALL, we analysed in an exploratory study these putative biological markers in leukaemic cells from 20 patients (age range 2-17.5 years; mean age 9 years). As not sufficient cell material was available from all 20 patients, interest was focused on telomerase.
Mononuclear cells of leukaemic samples were derived from 20 patients with T-ALL. Patients were enrolled in four consecutive multicenter trials of the Berlin-Frankfurt-Münster group (ALL-BFM 86, 90, 95 and 2000). According to the protocol guidelines, 14 of the patients were treated in the high risk (HR) arm and six patients in the intermediate risk (MR) arm. Prognosis (MR vs HR) and clinical outcome (treatment-induced remission vs relapse or death of disease) were assessed from the individual data of the patients.
Telomere length of samples was determined by telomere restriction fragment (TRF) Southern blot analysis, as previously reported.
11 Leukocytes from 19 children and adolescents (range: 3-17 years; mean age: 10 years) hospitalized for nonmalignant surgical procedures served as controls. TRF in seven of these controls has been reported recently. 11 We found that TRF varied widely (3.5-8.1 kb; mean7s.d.: 6.471.3 kb) in leukaemic cells and it was significantly shorter (Po0.0001, Mann-Whitney test) than that of age-matched controls (8.370.4 kb). Our observation was concordant with previous studies reporting reduction in
